滑液α-防御素是假体周围关节感染诊断不明确时的辅助工具
回顾性分析41例因近期使用抗生素、滑液细胞计数临界、疑似培养阴性或假阳性培养等诊断不明确情况而送检滑液α-防御素的病例,最终纳入39份滑液样本(32例患者),其中11份(28%)符合MSIS假体周围关节感染标准。滑液α-防御素总体灵敏度82%、特异度82%、阴性预测值92%、阳性预测值64%,在诊断不明确人群中易出现假阳性结果。
要点
- 在诊断不明确的病例中,滑液α-防御素总体灵敏度82%、特异度82%、阴性预测值92%、阳性预测值64%。
- 近期使用抗生素的23份样本中,α-防御素确认了19份(83%)的正确MSIS诊断。
- 细胞计数临界的11份样本中,α-防御素确认了10份(91%)的正确MSIS诊断。
核心结论
- 在因近期使用抗生素、实验室结果不明确或疑似培养假阴性或假阳性而导致假体周围关节感染诊断不明确的患者中,滑液α-防御素可提供额外数据点辅助临床医生判断是否存在感染,但在此类挑战性人群中易出现假阳性结果。
研究设计与样本
- 回顾性综述由单一外科医生连续送检滑液α-防御素的41例假体周围关节感染诊断不明确病例的滑液穿刺样本。
- 最终纳入32例患者的39份滑液样本,其中膝关节33份(85%)、髋关节6份(15%)。
- 假体周围关节感染采用肌肉骨骼感染学会(MSIS)标准诊断。
主要发现
- 39份样本中11份(28%)符合MSIS假体周围关节感染标准。
- 近期使用抗生素的23份样本(MSIS阳性6份、阴性17份)中,α-防御素确认了19份(83%)的正确MSIS诊断。
- 细胞计数临界的11份样本(MSIS阳性3份、阴性8份)中,α-防御素确认了10份(91%)的正确MSIS诊断。
- 疑似培养假阳性或假阴性的5份样本(MSIS阳性2份、阴性3份)中,α-防御素确认了3份(60%)的正确诊断。
- 滑液α-防御素总体灵敏度82%、特异度82%、阴性预测值92%、阳性预测值64%。
关键数值与推荐
- 假体周围关节感染诊断采用MSIS标准。
- 滑液α-防御素总体灵敏度82%、特异度82%、阴性预测值92%、阳性预测值64%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Synovial fluid alpha-defensin has shown to be a reliable diagnostic test for the diagnosis of periprosthetic joint infection (PJI), but its use in equivocal cases has yet to be established. The purpose of this study was to determine the reliability of alpha-defensin testing in patients, where the diagnosis of PJI was unclear. METHODS: A consecutive series of 41 synovial aspirations by a single surgeon that were sent for alpha-defensin testing in equivocal cases of PJI were retrospectively reviewed. Indications for alpha-defensin testing included recent antibiotic use, borderline synovial fluid cell count, and differential, suspected culture-negative infection, and suspected false-positive culture. PJI was diagnosed using the Musculoskeletal Infection Society (MSIS) criteria. RESULTS: Of the 39 aspirations in 32 patients included in the study, there were 33 (85%) knee and 6 (15%) hip samples. Eleven (28%) samples met MSIS criteria for PJI. Of the 23 samples that had recent antibiotic use (6 MSIS positive, 17 negative), alpha-defensin results confirmed the correct MSIS diagnosis in 19 (83%) samples. Of the 11 samples in which alpha-defensin testing was performed for a borderline cell count (3 MSIS positive, 8 negative), alpha-defensin confirmed the MSIS diagnosis in 10 of 11 (91%) samples. Finally, among the 5 samples with suspected false-positive or false-negative cultures (2 MSIS positive, 3 negative), alpha-defensin confirmed the correct diagnosis in 3 (60%) samples. The overall sensitivity, specificity, negative predictive value, and positive predictive value of synovial alpha-defensin were 82%, 82%, 92%, and 64%, respectively. CONCLUSION: In patients for whom the diagnosis of PJI is unclear because of recent antibiotic use, equivocal laboratory findings, or suspected false-negative or false-positive cultures, synovial fluid alpha-defensin can provide an additional data point to assist the clinician in determining whether PJI is present but is prone to false-positive results in this challenging population.
引用
- Kelly MP, Darrith B, Hannon CP, et al. Synovial Fluid Alpha-Defensin Is an Adjunctive Tool in the Equivocal Diagnosis of Periprosthetic Joint Infection. J Arthroplasty. 2018. PMID: 30017218. doi:10.1016/j.arth.2018.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。